Literature DB >> 12423825

An unusual presentation of struma ovarii mimicking a malignant process.

Vera Loizzi1, Fabio Cappuccini, Michael L Berman.   

Abstract

BACKGROUND: Struma ovarii is a rare form of ovarian neoplasm, composed entirely or predominantly of thyroid tissue. This tumor is generally benign, although malignant transformation has been reported. CASE: We report an unusual presentation of a postmenopausal woman with benign struma ovarii associated with a large amount of ascites, a markedly elevated CA 125 serum level, and a large complex pelvic mass thereby mimicking an ovarian cancer.
CONCLUSION: This case serves to remind clinicians that clinical features highly suspicious for ovarian cancer do not necessarily confirm a malignancy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423825     DOI: 10.1016/s0029-7844(02)02154-3

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Struma ovarii associated with pseudo-Meigs' syndrome and elevated serum CA 125: a case report and review of the literature.

Authors:  Wei Jiang; Xin Lu; Zhi Ling Zhu; Xi Shi Liu; Cong Jian Xu
Journal:  J Ovarian Res       Date:  2010-07-29       Impact factor: 4.234

Review 2.  Struma Ovarii with Pseudo-Meigs' Syndrome and Raised Cancer Antigen-125 Levels Masquerading as an Ovarian Carcinoma Case report and literature review.

Authors:  Surekha Yadav; Reena Tomar; Nidhi Verma; Nita Khurana; Rewa Triathi
Journal:  Sultan Qaboos Univ Med J       Date:  2017-06-20

Review 3.  Struma ovarii simulating ovarian sertoli cell tumor: a case report with literature review.

Authors:  Yan Ning; Fanbin Kong; Janiel M Cragun; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

Review 4.  Precise preoperative diagnosis of struma ovarii with pseudo-Meigs' syndrome mimicking ovarian cancer with the combination of 131I scintigraphy and 18F-FDG PET: case report and review of the literature.

Authors:  Sayaka Fujiwara; Hideaki Tsuyoshi; Toshiya Nishimura; Nozomu Takahashi; Yoshio Yoshida
Journal:  J Ovarian Res       Date:  2018-02-02       Impact factor: 4.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.